4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-004893
Chief Financial Officer sold 4,000 shares at $60.00 ($240,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Laponis Adam · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-17 | Sale : show line 1 in the form 10b5-1 | −4,000 | $60.00 | $240,000 | 118,694 | D |
| Open-market sales · 4,000 sh · avg $60.00 · $240,000 | ||||||
Loading xslF345X06/marketforms-72950.xml…